"Heilig"

During the past decade, Lungenklinik Lostau conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lungenklinik Lostau" #1 collaborator was "PneumRx, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lungenklinik Lostau" are "Emphysema" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Lungenklinik Lostau" in a lesser frequency.

Most popular intervention types in "Lungenklinik Lostau" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials) and "PneumRx Coil System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lungenklinik Lostau" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lungenklinik Lostau". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lungenklinik Lostau, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lungenklinik Lostau, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".